News for 'Wockhardt Group'

Drugmakers look to fill Rs 600 cr Novo vacuum

Drugmakers look to fill Rs 600 cr Novo vacuum

Rediff.com25 Sep 2025

Indian drugmakers Eris Lifesciences, Wockhardt and Lupin are prepping to cash in when Danish company Novo Nordisk bows out of the human insulin pen market by the end of this year and creates an opportunity estimated to be worth Rs 600-800 crore in the domestic market. Some self-use disposable pens are pre-filled with insulin and others can be reused with new cartridges.

Sons rise at Wockhardt

Sons rise at Wockhardt

Rediff.com6 Mar 2006

Wockhardt to open 7 hi-tech hospitals

Wockhardt to open 7 hi-tech hospitals

Rediff.com26 Sep 2008

The company will open seven new super speciality hospitals at major locations across the country and increase the bed capacity of some of its existing super speciality hospitals at an investment of Rs 700 crore (Rs 7 billion) by 2010. Currently, the company has 17 super speciality hospitals with over 2,000 in-patient beds across the country, four in Bangalore, three in Mumbai, two each in Nagpur, Hyderabad and Kolkata, and one each in Rajkot, Surat, Bhavnagar and Nashik.

Wockhardt to invest Rs 500 cr in 4 projects

Wockhardt to invest Rs 500 cr in 4 projects

Rediff.com9 Nov 2005

Pharma giant Wockhardt group promoted Wockhardt Hospital will invest Rs 500 crore (Rs 5 billion) in four Greenfield projects in the next three-year for its ultra super speciality clinics to be built in Mumbai, Delhi, Bangalore, and Kolkata.

Wockhardt to start 4 super speciality hospitals

Wockhardt to start 4 super speciality hospitals

Rediff.com12 Jul 2003

The Wockhardt Group plans to invest Rs 400-500 crore to establish new super speciality hospitals in Delhi, Mumbai, Kolkata and Bangalore in the next three years, a top official of the group said on Saturday.

Can Breast Cancer Reoccur After Mastectomy?

Can Breast Cancer Reoccur After Mastectomy?

Rediff.com16 Apr 2025

Even after the removal of breast tissue, it is possible that the cancer may recur in the chest wall or the area where the surgery was performed, warns Dr Meghal Sanghavi, oncosurgeon, at Wockhardt Hospitals.

What You Don't Know About Ambani, Adani Wealth

What You Don't Know About Ambani, Adani Wealth

Rediff.com21 Jan 2025

Ambani and Adani account for a fifth of the net worth of all billionaire promoters in the country and half the combined net worth of the top 10.

Can Stress, Dehydration Cause Stomach Pain?

Can Stress, Dehydration Cause Stomach Pain?

Rediff.com28 Feb 2025

When you're stressed, your body releases hormones like cortisol and adrenaline, which can interfere with your digestion process and cause excessive acid production, says Dr Aklesh Tandekar, head-consultant critical care, Wockhardt Hospitals.

Wockhardt gets approval for Ceftriaxone

Wockhardt gets approval for Ceftriaxone

Rediff.com15 May 2006

Pharmaceutical major Wockhardt Ltd said on Monday it has received USFDA approval for marketing the antibiotic Ceftriaxone Sodium injection in the US.

The Coming Dementia Epidemic

The Coming Dementia Epidemic

Rediff.com20 Dec 2024

Around 7.4 per cent of Indians aged 60 and above are affected by dementia. This number is expected to rise from the current 8.8 million to 17 million by 2036, marking a 97 per cent increase.

Wockhardt plans 2 hospitals in Hyderabad

Wockhardt plans 2 hospitals in Hyderabad

Rediff.com23 Apr 2005

Wockhardt Hospitals, a leading speciality hospital chain, on Saturday announced its plans to open two hospitals in Hyderabad.

Wockhardt buys France's Negma for Rs 1,090 cr

Wockhardt buys France's Negma for Rs 1,090 cr

Rediff.com3 May 2007

Pharma major Wockhardt on Thursday said it had acquired French pharmaceutical group Negma Laboratories for Rs 1,090.52 crore ($265 million) in cash -- a deal that would give it access to the European market.

Wockhardt gets CDR lifeline, with riders

Wockhardt gets CDR lifeline, with riders

Rediff.com10 Jul 2009

Wockhardt Chairman Habil Khorakiwala can breathe easy, as bankers have approved the debt restructuring package he had sought three months ago.

Wockhardt buys French firm for $265 mn

Wockhardt buys French firm for $265 mn

Rediff.com16 May 2007

Wockhardt Ltd said on Wednesday it has completed acquisition of France-based Negma Laboratories for $265 million.

'Don't allow Balkanisation of India'

'Don't allow Balkanisation of India'

Rediff.com29 Nov 2008

India should take up Pakistan's offer to help in curbing terrorism without any prejudice and work towards a terror-free South Asia, Fakruddin T Khorakiwala, founder, Wockhardt Group, said on Saturday.

Dr Reddy's to launch Covid drugs remdesivir and favipiravir in August

Dr Reddy's to launch Covid drugs remdesivir and favipiravir in August

Rediff.com30 Jul 2020

Apart from favipiravir and remdesivir, its key Covid-19 products, DRL has already launched nutraceutical products and hand sanitisers during the pandemic.

'You can't succeed without taking risk'

'You can't succeed without taking risk'

Rediff.com6 Jun 2018

'There are different kinds of risk.' 'It is a very powerful value. Your ability to de-risk the risk is also as important for risk taking.'

Home healthcare could be one of India's best bets

Home healthcare could be one of India's best bets

Rediff.com22 May 2021

Home healthcare remains a niche segment in India even today. Nightingale provides services, starting from family physicians, short- and long-term nursing care, post-hospitalisation care and physiotherapy to stroke rehabilitation, respiratory care, bedside caregivers and attendants, intensive care at home, lab tests and speech therapy.

Ministers Still CONTROL Business!

Ministers Still CONTROL Business!

Rediff.com28 Aug 2021

Indian businesses' weak ability to compete overseas says much about the infirmities imposed by the intensity of government dominance of economic policy and the nature of this dominance, observes Kanika Datta.

Oxford/AstraZeneca COVID-19 vaccine approved by UK regulator

Oxford/AstraZeneca COVID-19 vaccine approved by UK regulator

Rediff.com30 Dec 2020

The UK's National Health Service was already lining up thousands of medics and volunteers to be ready to deliver jabs up and down the country.

Fortis in talks to buy Lanka hospital chain

Fortis in talks to buy Lanka hospital chain

Rediff.com10 Dec 2009

Move comes within months of acquiring Wockhardt hospitals. Fortis Healthcare, a hospital chain promoted by former Ranbaxy owners Malvinder Mohan Singh and Shivinder Mohan Singh, is close to a major acquisition overseas

India Inc takes sale route to beat crisis

India Inc takes sale route to beat crisis

Rediff.com3 Sep 2009

Many, including DLF, Suzlon, UB, the Tata and the Aditya Birla Group are selling stake or assets to reduce debt and the strain on their balance sheets. That's because they have been hit either by slowing sales, or have a big exposure to markets in the West where demand has contracted sharply as a result of the economic downturn.

'US sales will also grow soon'

'US sales will also grow soon'

Rediff.com14 Jul 2006

Wockhardt Hospitals will expand to 10 to 15 hospitals over the next few years

As India learns to 'live' with COVID-19, hospitals brace for new normal

As India learns to 'live' with COVID-19, hospitals brace for new normal

Rediff.com12 May 2020

Most feel as the movement of people normalises, the in-patient volumes in hospitals will grow and by the end of May, occupancy should be around 50 per cent, and 75 per cent over a period of time.

'All my stocks are crashing. Hold them?'

'All my stocks are crashing. Hold them?'

Rediff.com3 Mar 2022

Ajit Mishra, vice president, research, Religare Broking, answers your queries.

Dozen more in billion dollar club

Dozen more in billion dollar club

Rediff.com24 Aug 2005

South pips North in healthcare

South pips North in healthcare

Rediff.com29 Aug 2007

Close to completing six decades in healthcare delivery, the Manipal Healthcare Group had a modest beginning with the Manipal Hospital in Bangalore

Corporate hospital sector witnesses healthy growth

Corporate hospital sector witnesses healthy growth

Rediff.com18 Dec 2006

The corporate hospital sector of the country is all set to take away a significant share of the tertiary healthcare service business from individual private healthcare providers by 2010.

Roche's Hepatitis C drug patent challenged

Roche's Hepatitis C drug patent challenged

Rediff.com12 Jun 2007

Swiss pharmaceutical major Hoffmann-La Roche's patents rights over Hepatitis C drug Pegasys has been challenged by public interest groups at the Indian Patent Office.

NSE revises circuit limits of over 1,400 scrips

NSE revises circuit limits of over 1,400 scrips

Rediff.com7 Nov 2013

This measure will ensure that the price of a scrip cannot move upward or downward beyond a limit set for the day.

Revealed! The top JOBS of 2020

Revealed! The top JOBS of 2020

Rediff.com30 Dec 2020

Naukri.com's Hiring Outlook Survey for 2020 reveals the jobs and sectors that saw a surge in demand during the pandemic.

Covid-19 could be the boost Indian pharma cos need

Covid-19 could be the boost Indian pharma cos need

Rediff.com20 Sep 2020

The western world had largely considered India to be a production hub, and also, a good potential geography for clinical trials, and a big market. But in Covid-19 research, Indian companies and government researchers are also researching new drug candidates and potential vaccines, says Prosenjit Datta.

Confused about the stock market? Here's Help

Confused about the stock market? Here's Help

Rediff.com23 Aug 2021

'Is it advisable to have more number of scrips in small quantities or a few scrips in big quantities?'

Over 340 drugs to go off the shelves soon

Over 340 drugs to go off the shelves soon

Rediff.com26 Jul 2018

Some of the popular brands that would be impacted include Phensedyl (Abbott), Tixylix (Abbott), Gluconorm PG (Lupin), Ascoril D (Glenmark), Solvin Cold (Ipca), D Cold Total (Paras Pharma).

'Advisable to invest in markets now?'

'Advisable to invest in markets now?'

Rediff.com7 May 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

As OPD footfalls drop, private hospitals battle for survival

As OPD footfalls drop, private hospitals battle for survival

Rediff.com11 Apr 2020

Private hospitals, especially smaller standalone ones, are staring at a crisis that they were not prepared for. Analysts say larger corporate chains have to brace up for at least six months for business to return to normal.